Concurrent Chemo-radiation Form NSCLC to a Individualized MLD (BRONC CONC MLD)

This study has been completed.

Sponsor:

Information provided by:

Maastricht Radiation Oncology

ClinicalTrials.gov Identifier:

NCT00572325

First received: December 12, 2007

Last updated: July 20, 2010

Last verified: July 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2009
Estimated Primary Completion Date:	No date given

No publications provided by Maastricht Radiation Oncology

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Dehing-Oberije C, Aerts H, Yu S, De Ruysscher D, Menheere P, Hilvo M, van der Weide H, Rao B, Lambin P. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325). Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):360-8. Epub 2010 Oct 1.

To Top